| Name | Mobocertinib succinate |
|---|---|
| Synonyms | MFCD32689632 |
| Description | Mobocertinib succinate (compound A) is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). |
| Molecular Formula | C36H45N7O8 |
|---|---|
| Molecular Weight | 703.78 |